64. 血栓性血小板減少性紫斑病 Thrombotic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 92 / 薬物数 : 85 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 76

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05468320 (ClinicalTrials.gov)	November 21, 2022	18/7/2022	Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults W ...	An Open-label, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of Caplacizumab and ...	Thrombotic Thrombocytopenic Purpura	Drug: Caplacizumab;Drug: Corticosteroids;Biological: anti-CD20 antibody	Sanofi	NULL	Recruiting	18 Years	80 Years	All	61	Phase 3	United States;Belgium;Czechia;France;Germany;Netherlands;Spain;United Kingdom
2	NCT00799773 (ClinicalTrials.gov)	April 2009	26/11/2008	Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopen ...	STAR - Study of TTP and Rituximab, A Randomized Clinical Trial	Thrombotic Thrombocytopenic Purpura	Drug: Rituximab;Procedure: Plasma exchange;Drug: Corticosteroids	New England Research Institutes	National Heart, Lung, and Blood Institute (NHLBI);Genentech, Inc.	Terminated	12 Years	N/A	All	3	Phase 3	United States
3	NCT00713193 (ClinicalTrials.gov)	November 2007	9/7/2008	Study of Cyclosporine or Corticosteroidsas an Adjunct to Plasma Exchange in Thrombotic Thrombocytope ...	A Multi-Center, Randomized Study of Cyclosporine or Corticosteroidsas an Adjunct to Plasma Exchange ...	Thrombotic Thrombocytopenic Purpura	Drug: Cyclosporine;Drug: Prednisone	Ohio State University	Food and Drug Administration (FDA)	Completed	18 Years	N/A	All	16	Phase 3	United States

First Previous1Next Last